Black Bird Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 24, 2021 at 12:20 am IST
Share
Black Bird Biotech, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 33.005 million compared to USD 29.971 million a year ago. Operating loss was USD 184.122 million compared to USD 36.545 million a year ago. Net loss was USD 265.814 million compared to USD 36.595 million a year ago. For the half year, sales was USD 35.212 million compared to USD 35.874 million a year ago. Operating loss was USD 366.872 million compared to USD 105.088 million a year ago. Net loss was USD 474.047 million compared to USD 105.149 million a year ago.
Black Bird Biotech, Inc. is a manufacturer and distributor for MiteXstream, an environmental protection agency (EPA)-certified plant-based biopesticide effective in the eradication of mites and other similar pests, including spider mites, that destroy crops, particularly cannabis, hops, coffee and house plants, as well as molds and mildew. The Company also manufactures and sells, under its Grizzly Creek Naturals brand name, cannabidiol (CBD) products, including CBD Oils, gummies and pet treats, as well as CBD-infused personal care products. Big Sky American Dist., LLC (Big Sky American) distributes its Grizzly Creek Naturals products, as well as an array of other consumer retail products, in Western Montana. The Company's subsidiaries include Black Bird Potentials Inc. (BB Potentials), Big Sky American Dist., LLC (Big Sky American) and Black Bird Hemp Manager, LLC.
BLACK BIRD BIOTECH, INC. 